The 12th Annual Summit for Women Leaders in Life Sciences Law 2025 (WILS 2025) brought together women from around the globe for forward-thinking discussions on current industry challenges and recent policy changes.
Attendees and panelists unpacked recent Executive Orders (EOs) in US legal responses and considered future implications for the life sciences sector.
CRA’s Erin McDermott and Taylor Rubinato, highlighted several key themes that emerged, including the impact of AI, the relevance of compounded medications, and the influence of recent EOs on research and development, drug approval timelines, and manufacturer revenues.
Read more about the evolving litigation risks here.
